Rule 38.5 - Pfizer INC ...
17 Novembro 2015 - 8:29AM
UK Regulatory
/**/
RNS Number : 9848F
Morgan Stanley Capital Services LLC
17 November 2015
FORM 38.5(a)
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH
RECOGNISED INTERMEDIARY STATUS AND DEALING IN A
CLIENT-SERVING CAPACITY
1.
KEY INFORMATION
|
Name of exempt
market-maker
|
Morgan Stanley Capital
Services LLC
|
|
Company dealt in
|
PFIZER INC
|
|
Class of relevant security to
which the dealings being disclosed relate (Note 1)
|
US$0.05 COMMON
STOCK
|
|
Date of dealing
|
16 NOVEMBER
2015
|
2.
DEALINGS (Note 2)
(a)
Purchases and sales
|
Total number of relevant
secuities accquired
|
Highest price paid (Note
3)
|
Lowest price paid (Note
3)
|
|
535,288
|
33.3900 USD
|
32.8500 USD
|
|
Total number of relevant
secuities disposed
|
Highest price paid (Note
3)
|
Lowest price paid (Note
3)
|
|
258,728
|
33.4000 USD
|
32.8550 USD
|
(b)
Derivatives transactions (other than options transactions)
|
Product name, e.g.
CFD
|
Nature of
transaction
(Note 4)
|
Number of relevant
securities
(Note 5)
|
Price per unit
|
|
CFD
|
LONG
|
240
|
32.9731 USD
|
|
CFD
|
LONG
|
3,200
|
32.9787 USD
|
|
CFD
|
LONG
|
1,350
|
33.0010 USD
|
|
CFD
|
LONG
|
90
|
33.0010 USD
|
|
CFD
|
LONG
|
286
|
33.0010 USD
|
|
CFD
|
LONG
|
11
|
33.0010 USD
|
|
CFD
|
LONG
|
7
|
33.0010 USD
|
|
CFD
|
LONG
|
93,338
|
33.0167 USD
|
|
CFD
|
LONG
|
147
|
33.0230 USD
|
|
CFD
|
LONG
|
62
|
33.0230 USD
|
|
CFD
|
LONG
|
4,300
|
33.0274 USD
|
|
CFD
|
LONG
|
2,000
|
33.0359 USD
|
|
CFD
|
LONG
|
8,500
|
33.0369 USD
|
|
CFD
|
LONG
|
80,348
|
33.0684 USD
|
|
CFD
|
LONG
|
36,837
|
33.0700 USD
|
|
CFD
|
LONG
|
400
|
33.0700 USD
|
|
CFD
|
LONG
|
1,400
|
33.0814 USD
|
|
CFD
|
LONG
|
14,500
|
33.0874 USD
|
|
CFD
|
LONG
|
100
|
33.0950 USD
|
|
CFD
|
LONG
|
100
|
33.0950 USD
|
|
CFD
|
LONG
|
6
|
33.0969 USD
|
|
CFD
|
LONG
|
71
|
33.0990 USD
|
|
CFD
|
LONG
|
143
|
33.0990 USD
|
|
CFD
|
LONG
|
94
|
33.1007 USD
|
|
CFD
|
LONG
|
9
|
33.1007 USD
|
|
CFD
|
LONG
|
200
|
33.1600 USD
|
|
CFD
|
LONG
|
100
|
33.2000 USD
|
|
CFD
|
LONG
|
9,190
|
33.2727 USD
|
|
CFD
|
LONG
|
500
|
33.2773 USD
|
|
CFD
|
SHORT
|
200
|
32.9400 USD
|
|
CFD
|
SHORT
|
8,900
|
32.9467 USD
|
|
CFD
|
SHORT
|
420
|
32.9493 USD
|
|
CFD
|
SHORT
|
231
|
32.9524 USD
|
|
CFD
|
SHORT
|
2,600
|
32.9542 USD
|
|
CFD
|
SHORT
|
4,032
|
32.9549 USD
|
|
CFD
|
SHORT
|
270
|
32.9549 USD
|
|
CFD
|
SHORT
|
31
|
32.9549 USD
|
|
CFD
|
SHORT
|
854
|
32.9549 USD
|
|
CFD
|
SHORT
|
19
|
32.9549 USD
|
|
CFD
|
SHORT
|
21
|
32.9600 USD
|
|
CFD
|
SHORT
|
56
|
32.9665 USD
|
|
CFD
|
SHORT
|
8,700
|
32.9681 USD
|
|
CFD
|
SHORT
|
18,867
|
32.9747 USD
|
|
CFD
|
SHORT
|
6,800
|
33.0021 USD
|
|
CFD
|
SHORT
|
51,700
|
33.0125 USD
|
|
CFD
|
SHORT
|
3,900
|
33.0253 USD
|
|
CFD
|
SHORT
|
5,200
|
33.0435 USD
|
|
CFD
|
SHORT
|
151,000
|
33.0499 USD
|
|
CFD
|
SHORT
|
1,637
|
33.0508 USD
|
|
CFD
|
SHORT
|
24,465
|
33.0508 USD
|
|
CFD
|
SHORT
|
116
|
33.0508 USD
|
|
CFD
|
SHORT
|
5,184
|
33.0508 USD
|
|
CFD
|
SHORT
|
194
|
33.0508 USD
|
|
CFD
|
SHORT
|
226
|
33.0525 USD
|
|
CFD
|
SHORT
|
544
|
33.0525 USD
|
|
CFD
|
SHORT
|
1,698
|
33.0763 USD
|
|
CFD
|
SHORT
|
90,400
|
33.0779 USD
|
|
CFD
|
SHORT
|
400
|
33.0825 USD
|
|
CFD
|
SHORT
|
200
|
33.0950 USD
|
|
CFD
|
SHORT
|
7,500
|
33.0993 USD
|
|
CFD
|
SHORT
|
10,492
|
33.1009 USD
|
|
CFD
|
SHORT
|
100
|
33.1100 USD
|
|
CFD
|
SHORT
|
100
|
33.1400 USD
|
|
CFD
|
SHORT
|
1,000
|
33.1509 USD
|
|
CFD
|
SHORT
|
567
|
33.1600 USD
|
|
CFD
|
SHORT
|
36,900
|
33.2658 USD
|
|
CFD
|
SHORT
|
3,333
|
33.3145 USD
|
(c)
Options transactions in respect of existing relevant securities
i)
Writing, selling, purchasing or varying
|
Product name, eg call
option
|
Writing, selling, purchasing,
varying etc
|
Number of securities to which
the option relates (Note 5)
|
Exercise Price
|
Type, e.g American, European
etc
|
Expiry Date
|
Option money paid/received per
unit (Note 3)
|
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
N/A
|
(ii) Exercising
|
Product name, eg call
option
|
Number of
securities
|
Exercise price per unit (Note
3)
|
|
N/A
|
N/A
|
N/A
|
3. OTHER INFORMATION
Agreements, arrangements or
understandings relating to options or derivatives
|
Full Details of any agreement,
arrangement or understanding between the person disclosing and any
other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to
the voting rights or future acquisition or disposal of any relevant
securities to which any derivative referred to on this form is
referenced. If none, this should be stated.
|
|
|
|
Date of disclosure
|
17 NOVEMBER 2015
|
|
Contact Name
|
Craig Horsley
|
|
Telephone Number
|
+44(141) 245 7736
|
|
Name of offeree/offeror with
which connected
|
ALLERGAN PLC
|
|
Nature of connection (Note
6)
|
Advisory
|
This information is provided by RNS
The company news service from the
London Stock Exchange
END
ISEBRBMTMBTBBPA
Pfizer (LSE:PFZ)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025
Pfizer (LSE:PFZ)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025
Notícias em tempo-real sobre Pfizer da Bolsa de Valores de Londres bolsa de valores: 0 artigos recentes
Mais Notícias de Pfizer
